Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | APC |
Variant | S1421Rfs*52 |
Impact List | frameshift |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | APC S1421Rfs*52 indicates a shift in the reading frame starting at amino acid 1421 and terminating 52 residues downstream causing a premature truncation of the 2843 amino acid Apc protein (UniProt.org). S1421Rfs*52 has not been characterized, however, due to the effects of other truncation mutations downstream of S1421 (PMID: 18199528, PMID: 10346819), is predicted to lead to a loss of Apc protein function. |
Associated Drug Resistance | |
Category Variants Paths |
APC mutant APC inact mut APC S1421Rfs*52 |
Transcript | NM_000038.6 |
gDNA | chr5:g.112839857delT |
cDNA | c.4263delT |
Protein | p.S1421Rfs*52 |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001407457.1 | chr5:g.(112840104_112840262) | c.(4261_4419) | p.S1421Rfs*52 | RefSeq | GRCh38/hg38 |
NM_001354905.2 | chr5:g.(112840335_112840493) | c.(4261_4419) | p.S1421Rfs*52 | RefSeq | GRCh38/hg38 |
NM_001407447.1 | chr5:g.(112839801_112839959) | c.(4261_4419) | p.S1421Rfs*52 | RefSeq | GRCh38/hg38 |
NM_001407456.1 | chr5:g.(112840104_112840262) | c.(4261_4419) | p.S1421Rfs*52 | RefSeq | GRCh38/hg38 |
NM_001354897.2 | chr5:g.(112839825_112839983) | c.(4261_4419) | p.S1421Rfs*52 | RefSeq | GRCh38/hg38 |
NM_001407448.1 | chr5:g.(112839801_112839959) | c.(4261_4419) | p.S1421Rfs*52 | RefSeq | GRCh38/hg38 |
NM_001354896.2 | chr5:g.(112839801_112839959) | c.(4261_4419) | p.S1421Rfs*52 | RefSeq | GRCh38/hg38 |
NM_001407449.1 | chr5:g.(112839801_112839959) | c.(4261_4419) | p.S1421Rfs*52 | RefSeq | GRCh38/hg38 |
NM_001354895.2 | chr5:g.112839857delT | c.4263delT | p.S1421Rfs*52 | RefSeq | GRCh38/hg38 |
NM_001127510.3 | chr5:g.112839857delT | c.4263delT | p.S1421Rfs*52 | RefSeq | GRCh38/hg38 |
NM_000038.6 | chr5:g.112839857delT | c.4263delT | p.S1421Rfs*52 | RefSeq | GRCh38/hg38 |
NM_001407455.1 | chr5:g.(112840104_112840262) | c.(4261_4419) | p.S1421Rfs*52 | RefSeq | GRCh38/hg38 |
NM_001407450.1 | chr5:g.112839857delT | c.4263delT | p.S1421Rfs*52 | RefSeq | GRCh38/hg38 |
NM_001407454.1 | chr5:g.(112840104_112840262) | c.(4261_4419) | p.S1421Rfs*52 | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
APC S1421Rfs*52 | colorectal cancer | sensitive | G007-LK | Preclinical - Cell culture | Actionable | In a preclinical study, G007-LK inhibited viability of a patient-derived colorectal cancer cell line harboring APC S1421Rfs*52 in culture (PMID: 37968472). | 37968472 |